Follow‐Up Questionnaires in Pharmacovigilance: A Quantitative Evaluation Based on Completeness Score
Pharmacoepidemiology and Drug Safety · 2026-12 · 35 (12)
DOI: 10.1002/pds.70527 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 18.11.2026. Verfasst von María Gordillo‐Marañón und 1 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Purpose
Follow‐up questionnaires (FUQs) are routinely used in pharmacovigilance to gather further information on suspected adverse drug reactions (ADRs) and are frequently included within Risk Management Plans. However, despite their extensive use and regulatory relevance, their contribution to improving the quality and completeness of case reports has not previously been evaluated quantitatively. The objective of this study was to assess whether the recommendation to implement or discontinue a FUQ was associated with changes in the completeness of information in case reports.
Methods
The minutes from January 2018 to July 2025 from the European Medicines Agency Pharmacovigilance Risk Assessment Committee (PRAC) were screened to identify recommendations regarding FUQ implementation or discontinuation. For active substance‐ADR combinations associated with a FUQ recommendation, case reports and a standardised measure of report completeness were obtained from EudraVigilance and VigiBase, the WHO global database of adverse event reports for medicines and vaccines, respectively. Interrupted time series analyses were conducted to assess the effect of specific FUQs on the quality of case reporting.
Results
Across the 27 active substance‐ADR combinations evaluated, the impact of FUQs on report completeness was heterogeneous. Only six combinations showed statistically significant trend changes, of which one demonstrated a small improvement in completeness after FUQ implementation and five showed declining trends following implementation ( n = 1) or discontinuation ( n = 4).
Conclusions
The present findings do not support a consistent association between FUQ implementation and improved case completeness. Other factors, including ADR‐related characteristics and heterogeneity in pharmacovigilance data collection practices, may be more important determinants of report quality. These findings provide the first quantitative evidence on FUQ effectiveness and support a more evidence‐based approach to their evaluation within pharmacovigilance systems.
Zitieren
APA
Gordillo‐Marañón, M., & Fernández‐Fernández, C. (2026). Follow‐Up Questionnaires in Pharmacovigilance: A Quantitative Evaluation Based on Completeness Score. Pharmacoepidemiology and Drug Safety, 35(12). https://doi.org/10.1002/pds.70527
Vancouver
Gordillo‐Marañón M, Fernández‐Fernández C. Follow‐Up Questionnaires in Pharmacovigilance: A Quantitative Evaluation Based on Completeness Score. Pharmacoepidemiology and Drug Safety. 2026;35(12). doi:10.1002/pds.70527
BibTeX
@article{GordilloMaran2026,
author = {Gordillo‐Marañón, María and Fernández‐Fernández, Cristina},
title = {Follow‐Up Questionnaires in Pharmacovigilance: A Quantitative Evaluation Based on Completeness Score},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2026},
volume = {35},
number = {12},
doi = {10.1002/pds.70527}
}
EUVIMED